Bronchial Diseases Not Yet Recruiting Phase 3 Trials for Pembrolizumab (DB09037)

Also known as: Bronchial Disease

IndicationStatusPhase
DBCOND0042791 (Bronchial Diseases)Not Yet Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04222972AcceleRET Lung Study of Pralsetinib for 1L RET Fusion-positive, Metastatic NSCLCTreatment